RGEN — Repligen Corporation stock price, charts and financials

QT62Repligen Corporation

Repligen Corporation (NASDAQ: RGEN) is a Healthcare company in the Medical - Instruments & Supplies industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
176.89
-1.30-0.73%
OverviewShort InterestFilings
RGENQT62Repligen Corporation·NASDAQ
176.89-0.73%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Sep 15, 20268-KCurrent report
Sep 08, 20264Statement of changes in beneficial ownership
Sep 08, 20268-KCurrent report
Sep 08, 2026425Prospectus / business-combination communication
Sep 04, 2026EFFECTNotice of effectiveness
Sep 04, 2026S-4/AS-4/A
Sep 04, 2026424B3Prospectus
Sep 02, 20264Statement of changes in beneficial ownership
Aug 25, 2026S-4Registration statement (M&A)
Aug 21, 20264Statement of changes in beneficial ownership
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 04, 2026425Prospectus / business-combination communication
Jul 31, 2026SC 13GBeneficial ownership statement (passive)
Jul 29, 202610-QQuarterly report
Jul 28, 20268-KCurrent report
Jul 24, 2026425Prospectus / business-combination communication
Jul 22, 20268-KCurrent report
Jul 22, 2026425Prospectus / business-combination communication
Jul 22, 2026425Prospectus / business-combination communication
Jul 17, 20264Statement of changes in beneficial ownership
Jun 26, 20264Statement of changes in beneficial ownership
May 18, 20264Statement of changes in beneficial ownership
May 18, 20264Statement of changes in beneficial ownership
May 18, 20264Statement of changes in beneficial ownership
May 18, 20264Statement of changes in beneficial ownership
#1 / 25 of 348
Page
▼
/ 14